BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2004
View Archived Issues
GW receives Qualifying Notice for Sativex in Canada
Read More
Positive results from mouse study of universal influenza A vaccine
Read More
FDA extends review of cilansetron NDA
Read More
Actelion begins global phase IIb/III program for clazosentan
Read More
Promics completes study of oral PMX-53 in rheumatoid arthritis
Read More
Activity of RAD-001 in hematologic malignancies studied in cells and patients
Read More
In vivo effects of bridging therapy with BAY-59-7939 in rats
Read More
Dosing begins in phase II obesity study of APD-356
Read More
Neurochem grants Centocor rights to Fibrillex
Read More
Bristol-Myers Squibb and Somerset sign agreement for Emsam
Read More
Access files IND for U.S. clinical studies of AP-5346
Read More
OXI-4503 enters U.K. phase I trial in advanced cancer patients
Read More
IoGen enters pivotal phase III study for fibrocystic breast disease
Read More
Pharmagene updates progress
Read More
Disappointing topline results from phase III study of alvimopan
Read More
Ortho-McNeil selects Arena compounds for preclinical development
Read More
Bristol-Myers Squibb submits muraglitazar NDA
Read More
Rolling BLA for abatacept to be completed in early 2005
Read More
Approval of the merger of Aventis with and into sanofi-aventis
Read More
Advate approved in Europe for children under six with hemophilia A
Read More
Bz-423, a novel benzodiazepine, suppresses cell growth in an in vitro psoriasis model
Read More
New treatment for Parkinson's disease described in patent literature
Read More
Cdk inhibitors in early development at GPC Biotech
Read More
TaiGen Biotechnology patent discloses CXCR3 receptor antagonists
Read More
Novel agents for treatment of hepatitis C infection described in a patent
Read More
Pfizer team reports series of PPAR agonists for dyslipidemia, hypercholesteremia, etc.
Read More
5-HT1B receptors are involved in cocaine sensitization
Read More
Novel estrogen receptor antagonist for ER-sensitive breast cancer
Read More
First clinical data for novel antidepressant published
Read More